DEXCOM (DC4 BE) stock market data APIs
€55.8778
0(0%)
as of October 17, 2025
Try our APIs with
free plan!
DEXCOM Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for DC4.BE.
Prev. Close
55.8778
Open
55.8778
High
55.8778
Low
55.8778
52 wk Range
51.8-86.3
Market Cap
48 618 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DEXCOM data using free add-ons & libraries
Get DEXCOM Fundamental Data
DEXCOM Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DEXCOM News
New
American Diversified Holdings Corporation Receives $5,000,000 (Five Million) Financing Commitment from an Institutional Investment Fund
Del Mar, California--(Newsfile Corp. - October 16, 2025) - American Diversified Holdings Corporation (OTCID: ADHC) announced today that a prominent institutional investment fund has committed to provi...
Here’s Why Artisan Mid Cap Fund Exited Dexcom (DXCM)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equity markets conti...
The Bull Case For DexCom (DXCM) Could Change Following Cautious Full-Year Outlook Amid Sector Selloff
Earlier this month, DexCom reported stronger-than-expected second quarter revenues but issued the weakest full-year outlook among patient monitoring peers, following a sector-wide selloff triggered by...
DexCom (DXCM): Valuation in Focus After Q2 Revenue Beat and Cautious Outlook on Sector Tensions
DexCom (DXCM) shares are in the spotlight after the company delivered better-than-expected second quarter revenues. However, a softer full-year outlook has drawn investor caution. Sector-wide trade te...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
